Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
Nadia Tarhini, Clinical Research Assistant at Boston Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“I’m excited to announce my first co-authorship on a research publication!
I’m incredibly grateful for the opportunity to contribute to this project and gain a more in-depth knowledge about venous thrombo-embolisms among pediatric patients with acute lymphoblastic leukemia.
A special thank you to Dr. Riten Kumar on the opportunity to work collaboratively on this project and Dr. Olivia Perrone and Dr. Lynda Vrooman for their ongoing support and guidance throughout BCH/DFCI’s contribution on this project!”
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, reposted Nadia Tarhini’s post on LinkedIn:
“Was great to collaborate with Dr Pelland-Marcotte on this multicenter study evaluating the risk of recurrent thrombosis in children with ALL.
Notably, the risk of recurrence remains substantial, with most patients experiencing recurrent thrombosis early during treatment.
These findings underscore the need for better predictors of thrombus progression and recurrence in children with cancer associated thrombosis.”
Title: Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia
Authors: Marie-Claude Pelland-Marcotte, Thai Hoa Tran, Chantal Éthier, Camille Beaulieu, Thien Vu Truong, Olivia Perrone, Nadia Tarhini, Juliann Duzan, Lynda M. Vrooman, Melissa Burns, Lewis B. Silverman, Riten Kumar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C